Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
about
Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial.Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements.Plasmin generation and fibrinolysis in pediatric patients undergoing cardiopulmonary bypass surgery.
P2860
Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
@en
Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
@nl
type
label
Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
@en
Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
@nl
prefLabel
Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
@en
Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
@nl
P2093
P1476
Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
@en
P2093
Gabriel S Aldea
Kristy Seidel
Michael J Eisses
Wayne L Chandler
P304
1208-16, table of contents
P356
10.1213/01.ANE.0000108489.88613.2C
P407
P577
2004-05-01T00:00:00Z